Financial Enhancement Group LLC Laboratory Corp Of America Holdings Transaction History

Financial Enhancement Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	SELL	$204.81 - $262.19 $2.71 Million - $3.48 Million	-13,256 Reduced 44.98%	16,217 $3.32 Million
Q2 2022 Aug 09, 2022	BUY	$213.86 - $277.87 $692,692 - $900,020	3,239 Added 12.35%	29,473 $6.91 Million
Q1 2022 May 18, 2022	SELL	$259.82 - $298.18 $1.58 Million - $1.81 Million	-6,074 Reduced 18.8%	26,234 $6.92 Million
Q4 2021 Jan 28, 2022	BUY	$271.6 - $314.21 $253,402 - $293,157	933 Added 2.97%	32,308 $10.2 Million
Q3 2021 Oct 14, 2021	BUY	$274.82 - $308.34 $768,121 - $861,810	2,795 Added 9.78%	31,375 $8.83 Million
Q2 2021 Aug 10, 2021	SELL	$251.87 - $278.14 $239,024 - $263,954	-949 Reduced 3.21%	28,580 $7.88 Million
Q1 2021 May 10, 2021	BUY	$204.88 - $255.03 $6.05 Million - $7.53 Million	29,529 New	29,529 $7.53 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

Stay updated on Financial Enhancement Group LLC with notifications on news.